You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CEFOXITIN SODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for cefoxitin sodium and what is the scope of freedom to operate?

Cefoxitin sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Hospira Inc, B Braun, Norvium Bioscience, Merck, and Samson Medcl, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for cefoxitin sodium. Six suppliers are listed for this compound.

Summary for CEFOXITIN SODIUM
US Patents:0
Tradenames:7
Applicants:10
NDAs:18
Drug Master File Entries: 6
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 70
Clinical Trials: 1
Patent Applications: 2,692
What excipients (inactive ingredients) are in CEFOXITIN SODIUM?CEFOXITIN SODIUM excipients list
DailyMed Link:CEFOXITIN SODIUM at DailyMed
Recent Clinical Trials for CEFOXITIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all CEFOXITIN SODIUM clinical trials

Pharmacology for CEFOXITIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFOXITIN SODIUM

US Patents and Regulatory Information for CEFOXITIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norvium Bioscience MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065238-001 Mar 12, 2010 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Farmaceutica CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065238-002 Mar 12, 2010 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065012-001 Jul 3, 2000 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065313-002 Jan 23, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414-001 Jun 12, 2009 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 062757-001 Jan 8, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.